Clinical impact and prognosis of cryoglobulinemia and cryofibrinogenemia in systemic sclerosis
S. De Almeida Chaves(Centre Hospitalier Universitaire de Toulouse), G. Pugnet(Hôpital Rangueil), F. Gaches, D. Adoué, L. Sailler(Université Fédérale de Toulouse Midi-Pyrénées), Martin Michaud(Centre Hospitalier Universitaire de Toulouse), Olivier Lairez(Hôpital Rangueil), L. Astudillo(Hôpital Purpan), Bénédicte Puissant‐Lubrano, Grégoire Prévôt(Hôpital Larrey), Laurent Alric, David Ribes(Centre Hospitalier Universitaire de Toulouse), T. Porel, Antoine Huart, Eva Bories
Cited by 7
Related Papers
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Proinflammatory Cytokines, Aging, and Age-Related Diseases
|Journal of the American Medical Directors Association|2013|1.1k
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study
|The Lancet Infectious Diseases|2017|587
Pregnancy-Associated Hemolytic Uremic Syndrome Revisited in the Era of Complement Gene Mutations
|Journal of the American Society of Nephrology|2010|470